FDA Inspection
Senador Laboratories Private LimitedFDA Inspection 1305216 - Senador Laboratories Private Limited - November 24, 2025
Record Details
This FDA Inspection record concerns Senador Laboratories Private Limited, with an inspection on November 24, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · bcdf9200-ea91-4965-8935-13c8a06d8408
Inspection Facts
- Inspection number
- 1305216
- FDA center
- Human Drugs
Other FDA inspections of Senador Laboratories Private Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Senador Laboratories Private Limited
- FDA Inspection 1107337 - 2019-09-16
- FDA Inspection 1037438 - 2017-11-24
- FDA Inspection 1028107 - 2017-08-29
- FDA Inspection 891441 - 2014-07-25
- FDA Inspection 790200 - 2012-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.